Maravai LifeSciences (MRVI) Tops Q2 EPS by 8c

Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $242.7 million versus the consensus estimate of $234.47 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Raymond James Starts Mid Penn Bancorp (MPB) at Outperform
• Zhen Ding Technology Holding Limited (4958:TT) (HASGF) PT Raised to NT$720 at Nomura/Instinet